EGFR TKIs for advanced NSCLC: practical questions.
Perez-Soler
Roman
R
Division of Oncology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D018579:Patient Selection; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D016879:Salvage Therapy
D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors